GB0321309D0 - Crystalline therapeutic agent - Google Patents
Crystalline therapeutic agentInfo
- Publication number
- GB0321309D0 GB0321309D0 GB0321309A GB0321309A GB0321309D0 GB 0321309 D0 GB0321309 D0 GB 0321309D0 GB 0321309 A GB0321309 A GB 0321309A GB 0321309 A GB0321309 A GB 0321309A GB 0321309 D0 GB0321309 D0 GB 0321309D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic agent
- crystalline therapeutic
- crystalline
- agent
- therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0321309A GB0321309D0 (en) | 2003-09-11 | 2003-09-11 | Crystalline therapeutic agent |
US10/763,794 US20040235857A1 (en) | 2003-02-11 | 2004-01-22 | Crystalline therapeutic agent |
PCT/IB2004/000315 WO2004072079A1 (en) | 2003-02-11 | 2004-02-05 | Hydrated and anhydrous sildenafil hemi-citrate compound |
ARP040100410A AR043143A1 (en) | 2003-02-11 | 2004-02-10 | CRYSTAL VARIETY OF HYDRAPHY SILDENAFIL CITRATE AND ITS USE AS A THERAPEUTIC AGENT |
TW093103036A TW200500068A (en) | 2003-02-11 | 2004-02-10 | Crystalline therapeutic agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0321309A GB0321309D0 (en) | 2003-09-11 | 2003-09-11 | Crystalline therapeutic agent |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0321309D0 true GB0321309D0 (en) | 2003-10-15 |
Family
ID=29226914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0321309A Ceased GB0321309D0 (en) | 2003-02-11 | 2003-09-11 | Crystalline therapeutic agent |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB0321309D0 (en) |
-
2003
- 2003-09-11 GB GB0321309A patent/GB0321309D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0303910D0 (en) | Therapeutic agents | |
GB0308318D0 (en) | Therapeutic agents | |
GB0314079D0 (en) | Therapeutic agents | |
GB0314057D0 (en) | Therapeutic agents | |
GB0313250D0 (en) | Therapeutic agents | |
GB0310401D0 (en) | Therapeutic agent | |
GB0323378D0 (en) | Therapeutic agent | |
GB0314049D0 (en) | Therapeutic agents | |
GB0323258D0 (en) | Therapeutic compounds | |
GB0311859D0 (en) | Therapeutic agents | |
GB0311201D0 (en) | Therapeutic agents | |
GB0301350D0 (en) | Therapeutic agents | |
GB0304524D0 (en) | Therapeutic agents | |
GB0314075D0 (en) | Therapeutic agents | |
GB0314078D0 (en) | Therapeutic agents | |
GB0307333D0 (en) | Therapeutic agent | |
GB0303097D0 (en) | Crystalline therapeutic agent | |
GB0321309D0 (en) | Crystalline therapeutic agent | |
GB0303084D0 (en) | Chrystalline therapeutic agent | |
GB0307335D0 (en) | Therapeutic agent | |
GB0310402D0 (en) | Therapeutic agent | |
EP1627632A4 (en) | Therapeutic agent | |
GB0327426D0 (en) | Therapeutic compounds | |
GB0327425D0 (en) | Therapeutic compounds | |
GB0315140D0 (en) | Therapeutic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |